Where Tech Meets Bio
Latest News
Research Grid has secured $6.48 million in seed funding, led by Fuel Ventures, with additional support from Arve Capital, Ada Ventures, and Morgan Stanley Inclusive …
Read More
UK Life Sciences Venture Capital Outperforms General Market: British Business Bank Report
New research from the British Business Bank reveals that life sciences venture capital (VC) funds are delivering higher realized returns for investors compared to the …
Read More
New AI-Enhanced Architecture for EHDS2 Implementation Released
BC Platforms, Modirum Platforms, VEIL.AI, and Productivity Leap have jointly developed a reference architecture to implement the European Health Data Space secondary (EHDS2) framework, enabling …
Read More
Latest News
BC Platforms Unveils Platform to Unify EU Healthcare Data Governance
UK Government and Oxford Nanopore to Launch Pandemic Early Warning System
Elsevier Supports Pistoia Alliance to Tackle AI Challenges in Drug Discovery
Accenture Invests in 1910 Genetics to Enhance Drug Discovery With AI
Evogene Partners with Google Cloud to Build AI Model for Small Molecule Discovery
Absci and Twist Bioscience Collaborate to Design a Novel Antibody with Generative AI
Latest Insights
by BiopharmaTrend
Top AI in Pharma and Healthcare Conferences in 2024 You Can’t Miss
Artificial intelligence, particularly machine learning and deep learning, has increasingly become a focal point in the life sciences and healthcare sectors. As the integration of …
Read More
by Andrii Buvailo
19 Companies Pioneering AI Foundation Models in Pharma and Biotech
Foundation models represent a new paradigm in artificial intelligence (AI), revolutionizing how machine learning models are developed and deployed. As these models grow increasingly capable, …
Read More
Cautious Optimism in 2024 for Healthcare M&A
by Merlin Piscitelli
AI Is Key to Democratizing Drug Discovery
by Andrey Doronichev
Key Trends in Aging Research: Where Are We Now?
by Andrii Buvailo, PhD
Global Pharma R&D Investments Surpass $276 Billion Annually, Exceeding Previous Estimates
by Roman Kasianov
The Promise of Chatbots in Clinical Trials
by Illia Petrov
Even 10 Minutes Matter in Cancer Research
by Andrii Buvailo, PhD
How Enterprise Architecture is Powering Digital Transformation in Healthcare
by Rupert Colbourne
UK-based Laverock Therapeutics Expands Gene-Silencing Technology to Tackle Multiple Disease Areas
by Roman Kasianov
From Our Partners
Sponsored by
Intelligencia AI
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Sponsored by
RECEPTOR.AI
This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery
Sponsored by
Lantern Pharma
AI Breaches the Barrier Towards Better CNS Drug Discovery
Sponsored by
Syntekabio
How to Discover a Preclinical Drug Candidate in Two Years
Partner Events
London Biotechnology Show 2025
Event Date: June 18, 2025 - June 19, 2025
Location: United Kingdom (Hall N7 & N8 Bett Global, Excel London, Royal Victoria Dock, 1 Western Gateway, London, UK, England, GB, E16 1XL)
Website: Link
Promo Code: 4CPHAK
Read more ›››
Future Labs, Automation and Technology Summit West
Event Date: Nov. 12, 2024 - Nov. 12, 2024
Location: United States of America (San Diego, California)
Website: Link
Promo Code: BIOPHARMA15
Read more ›››
BIOCHINA 2025
Event Date: March 13, 2025 - March 15, 2025
Location: China (Suzhou International Expo Center)
Website: Link
Promo Code: biopharmatrend (valid till 2024-10-31)
Read more ›››
Case Studies
Sponsored by
Bioz
Bioz Badges — Advanced Data-Widgets for Confident E-commerce
Sponsored by
Lantern Pharma
Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®
Sponsored by
Kymera Therapeutics
Identifying High Impact Tissue Sparing E3 Ligases and Their Binders
Sponsored by
Trialize
Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days
Sponsored by
Arctoris
Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery
Sponsored by
Celeris Therapeutics
Application of AI-driven Xanthos Platform for Designing Protein Degraders
Sponsored by
Science Exchange
How Astellas Pharma Achieves R&D Operational Excellence with Science Exchange
Sponsored by
Biocompare
Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness
Interviews
[Interview] A Company on the Cutting Edge of COVID-19 Vaccine Development
Navigating Next Wave of Protein Design with Elise de Reus from Cradle
Pioneering the Largest Foundation Model to Transform RNA Research: An Interview with Brendan Frey
Rethinking Clinical Trials: Tim Smith on Medable’s Approach to Speed and Efficiency
Most Read
5 AI-Powered Companies Transforming the Future of Fertility Care
21 Life Science Marketplaces to Try in 2024
9 Notable AI Companies in Clinical Research to Watch in 2023
13 Publicly Traded Biotechs Utilizing AI-based Research Platforms (+ 2 Upcoming Public Debuts)